Acurx Pharmaceuticals (ACXP) Current Assets (2021 - 2025)

Acurx Pharmaceuticals' (ACXP) quarterly Current Assets came in at $6.2 million in Q2 2025, up 28.14% on a QoQ basis from $4.8 million in Q1 2025.

Acurx Pharmaceuticals (ACXP) Current Assets (2021 - 2025) Analysis & Trends

Acurx Pharmaceuticals (ACXP) has 5 years of Current Assets data on file, last reported at $6.2 million in Q2 2025.

Quarterly Current Assets changed N/A year-over-year to $6.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $6.2 million (changed N/A YoY) and the FY2024 annual result came in at $3.9 million, down 49.96% from the prior year.
Current Assets advanced to $6.2 million in Q2 2025, from $4.8 million in the prior quarter.
In the past five years, Current Assets ranged from a high of $13.3 million in Q4 2021 to a low of $3.9 million in Q4 2024.
A 5-year average of $7.9 million and a median of $7.5 million in 2023 frame the typical range for Current Assets.
Annual changes were most pronounced in 2023 — Current Assets advanced 0.29% — and 2024, when it sank 49.96%.
Tracing ACXP's Current Assets over 5 years: stood at $13.3 million in 2021, then slipped by 29.25% to $9.4 million in 2022, then dropped by 17.78% to $7.7 million in 2023, then slumped by 49.96% to $3.9 million in 2024, then jumped by 59.61% to $6.2 million in 2025.
The last three Current Assets figures came in at $6.2 million (Q2 2025), $4.8 million (Q1 2025), and $3.9 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Assets (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	12.54 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	18.45 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	8.07 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	5.82 Bn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	7.22 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	4.62 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	1.63 Bn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	1.76 Bn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	18.80 Bn
10	Acurx Pharmaceuticals	6.18 Mn	6.18 Mn	-	-

Download Data